Cargando…
Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process
According to the latest available data, cancer is the second leading cause of death, highlighting the need for novel cancer therapeutic approaches. In this context, immunotherapy is emerging as a reliable first-line treatment for many cancers, particularly metastatic melanoma. Indeed, cancer immunot...
Autores principales: | Feola, Sara, Chiaro, Jacopo, Martins, Beatriz, Cerullo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352969/ https://www.ncbi.nlm.nih.gov/pubmed/32585818 http://dx.doi.org/10.3390/cancers12061660 |
Ejemplares similares
-
PeptiCHIP:
A Microfluidic Platform for Tumor Antigen
Landscape Identification
por: Feola, Sara, et al.
Publicado: (2021) -
Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy
por: Peltonen, Karita, et al.
Publicado: (2021) -
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses
por: Hamdan, Firas, et al.
Publicado: (2021) -
A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
por: Fusciello, Manlio, et al.
Publicado: (2022) -
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
por: Ylösmäki, Erkko, et al.
Publicado: (2021)